Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals
Author(s) -
J. El-On,
Geoffrey P. Jacobs,
Eliezer Witztum,
Charles L. Greenblatt
Publication year - 1984
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.26.5.745
Subject(s) - cutaneous leishmaniasis , pharmacology , leishmaniasis , sodium stibogluconate , paromomycin , pentamidine , allopurinol , amphotericin b , leishmania major , leishmania , antiparasitic agent , microbiology and biotechnology , drug , medicine , antibiotics , immunology , biology , pneumonia , parasite hosting , antifungal , pathology , aminoglycoside , world wide web , computer science
Topical treatment, with drug-containing ointments, of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice was studied. Twenty chemotherapeutic agents having potential or established antileishmanial activity were formulated in different ointment and cream bases. Only 15% paromomycin sulfate with 12% methylbenzethonium chloride, 12% benzethonium chloride, 12% cetalkonium chloride, or 12% dimethyl sulfoxide, all incorporated in white soft paraffin (United Kingdom patent application no. 2117237A), were completely effective. Topical treatment twice daily for 6 or more days caused total elimination of the parasites and healing of the lesion in all treated mice. All the other antileishmanial compounds, including sodium stibogluconate, pentamidine, amphotericin B, emetine hydrochloride, metronidazole, co-trimoxazole, allopurinol, and rifampin, either showed a slight effect on the parasites or were highly toxic to the animal host at the concentrations tested.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom